TransMedics Group Inc (NAS:TMDX)
$ 83 -1.97 (-2.32%) Market Cap: 2.79 Bil Enterprise Value: 3.04 Bil PE Ratio: 88.30 PB Ratio: 13.26 GF Score: 77/100
Back to the Transcripts List

Q3 2024 Transmedics Group Inc Earnings Call Transcript

Oct 28, 2024 / 08:30PM GMT
Release Date Price: $126.24 (+0.85%)

Key Points

Positve
  • TransMedics Group Inc (TMDX) reported a 64% year-over-year revenue growth for Q3 2024, driven by a 76% increase in US sales.
  • The company has expanded its fleet to 18 owned aircraft, enhancing its logistics and aviation infrastructure.
  • TransMedics Group Inc (TMDX) is investing in next-generation OCS heart and lung technologies, with plans to launch new clinical programs in 2025.
  • The company maintained its annual revenue guidance range of $425 million to $445 million, representing 76% to 84% growth over 2023.
  • TransMedics Group Inc (TMDX) achieved a GAAP operating profit of $3.9 million in Q3, representing 4% of total revenue.
Negative
  • The company experienced a 5% sequential decline in total revenue from Q2 2024, with US sales declining 3% and OUS sales declining 45%.
  • Gross margins decreased to 56% in Q3 from 61% in Q2 2024, due to continued investments in logistics and reliance on third-party logistics partners.
  • TransMedics Group Inc (TMDX) faced headwinds from a decline in US national transplant volumes, impacting case volumes.
  • The company incurred approximately $2 million in non-recurring costs related to logistics and infrastructure investments.
  • There was a higher reliance on third-party logistics partners due to aircraft maintenance, affecting service margins.
Operator

Good afternoon and welcome to the Transmedics third quarter, 2024 earnings conference call. (Operator Instructions)

I would now like to turn the call over to Laine Morgan from the Gilmartin Group for a few introductory comments.

Laine Morgan
Gilmartin Group - Investor Relations

Thanks Operator. Earlier today, Transmedics released financial results for the quarter ended September 30, 2024, a copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make statements during this call including during the question-and-answer portion of the call that include forward-looking statements within the meaning of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results or performance or forward-looking statements.

All forward-looking statements including without limitation, our examination of operating trends, the potential commercial opportunity for our current and next generation products, services and

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.